Subhash Krishnamoorthy, MD

Dr. Wei is an Assistant Professor of Medicine and Medical Oncologist specializing in the treatment of prostate, bladder, kidney, and other genitourinary cancers at the Herbert Irving Comprehensive Cancer Center at Columbia University. In addition to his clinical responsibilities, he is also a clinical trial investigator within the Genitourinary Oncology Research Program and the Phase 1 Experimental Therapeutics Program where he seeks to identify novel cancer treatments to improve patient outcomes. Alexander Z. Wei, MD, received his Bachelor of Science and Master of Science in Immunology, Microbiology, and Virology at the University of Rochester. He then earned his medical degree from the John A. Burns School of Medicine at the University of Hawaii with a distinction in medical education. Following medical school, Dr. Wei completed both his Internal Medicine residency and Medical Oncology fellowship at Columbia University Irving Medical Center, where he was awarded the Dr. Joseph N. Muschel Housestaff Award and also served as chief fellow. During his fellowship, he focused on the identification and use of novel therapies in lung cancer and melanoma through early-phase clinical trials. He was selected to attend the ASCO/AACR Methods in Clinical Trials Research workshop where he further developed his acumen in clinical trial design. For his work in identifying uveal melanoma patients at risk for developing brain metastases, Dr. Wei was awarded the Jed Ian Taxel Rare Cancer Foundation Young Investigator Award. After discovering an interest in genitourinary oncology, his research now aims to utilize new treatments in locally advanced, muscle-invasive bladder cancer patients to potentially reduce the burden of surgery and the identification of novel agents to improve survival and quality of life in patients with advanced urothelial cancers.

Dr. Timothy Wang is a leading expert in gastroenterology cancer research and patient care. His research specifically focuses on transgenic/ knockout mice, stem cells, lineage tracing, bone marrow-derived cells, and FACS analysis of immune/epithelial cells in the gut. His laboratory has for decades investigated the molecular mechanisms of gastrointestinal carcinogenesis, and has been continuously funded by the NIH for 29 years and by the NCI for 14 years. His lab has worked for many years on the role of inflammation in promoting gastrointestinal neoplasia, including colon cancer. His research has defined key roles for stromal cells in tumor development, including myeloid cells. Dr. Wang is the GI Division Chief at Columbia and serves as Co-leader of the Tumor Biology and Microenvironment Program of the Herbert Irving Comprehensive Cancer Center. He also serves as director of the Columbia University NCI U54 Tumor Microenvironment (TMEN) program and directs the Barrett’s Esophageal Translational Research Network (BETRNet) program and the Intestinal Stem Cell Consortium (ISCC) at Columbia. In addition to his leadership at Columbia, Dr. Wang has served as President of the American Gastroenterology Association (AGA). His work has been recognized with numerous awards, including the Outstanding Investigator Award from the NCI, the Irene and Arthur Fishberg Prize for medical research, the Ruth Leff Siegel Award for pancreatic cancer research, and the William Beaumont Prize in Gastroenterology from the AGA. Over his career, he has organized numerous conferences, including conferences on Gastrin, Regulatory Peptides, AACR Symposium on Gastric Cancer, Tumor Microenvironment, and Keystone Conferences.

Karan Dua, MD is an Orthopedic surgeon specializing in the treatment of structures affecting the form and function of the entire arm. Karan is a Brooklyn native, and a proud member of the New York community. After earning his Doctorate of Medicine (MD) from Stony Brook University School of Medicine, he completed an Orthopedic Surgery Residency at Downstate Medical Center in Brooklyn, NY. He has dedicated his career to studying and training in the surgical management of the Upper Extremity. He first completed a Hand, Upper Extremity, and Microvascular Surgery Fellowship at Rush University Medical Center in Chicago, IL. Upon completion, he trained at Harvard Medical School for his Shoulder and Elbow Fellowship at Massachusetts General Hospital in Boston, MA. Karan is on the forefront of researching and designing innovative, novel surgical techniques for reconstructing the arm. He has an avid interest in open and arthroscopic tendon transfers of the shoulder, complex reconstructions after failed surgery, arthroscopic and minimally invasive techniques for nerve decompression including the brachial plexus and around the shoulder blade, and tendon transfers for scapular winging. Karan is a passionate researcher and writer. He has been awarded multiple research grants studying wrist and elbow reconstruction techniques, nerve gliding in the upper extremity, and continues to pursue these efforts at Columbia University. He has published over 30 peer reviewed journal articles, authored several book chapters in leading Orthopedic surgery textbooks, and presented his research at national and international conferences. Dr. Dua is a participating member of the American Academy of Orthopaedic Surgeons (AAOS), American Society for Surgery of the Hand (ASSH), and the American Shoulder and Elbow Surgeons (ASES). Karan strives to help his patients achieve their functional goals and works rigorously to improve their experience. He strongly believes in incorporating new technologies to accomplish this, and works in a collaborative manner with his colleagues to create unique treatment plans that are specifically tailored to each patient. He continues to foster an inclusive care environment while developing meaningful relationships with the members of this community.